SEARCH

SEARCH BY CITATION

References

  • 1
    Pilbeam CC, Harrison JR, Raisz LG 2002 Prostaglandins and bone metabolism. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, New York, NY, USA, pp. 979994.
  • 2
    Smith WL, Garavito RM, DeWitt DL 1966 Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 3315733160.
  • 3
    Herschman HR 1996 Prostaglandin synthase 2. Biochim Biophys Acta 1299: 125140.
  • 4
    Rosen V, Cox K, Hattersley G 1996 Bone morphogenetic proteins. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, New York, NY, USA, pp. 661671.
  • 5
    Yamaguchi A, Komori T, Suda T 2000 Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21: 393411.
  • 6
    Reddi AH 1994 Bone and cartilage differentiation. Curr Opin Genet Dev 4: 737744.
  • 7
    Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K 1995 Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 10: 16811690.
  • 8
    Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T 1999 Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1 alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 259: 97102.
  • 9
    Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC 2000 Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: Antagonism by noggin. J Bone Miner Res 15: 663673.
  • 10
    Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T 1998 Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273: 18721879.
  • 11
    Attisano L, Wrana JL 2000 Smads as transcriptional co-modulators. Curr Opin Cell Biol 12: 235243.
  • 12
    Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747754.
  • 13
    Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755764.
  • 14
    Hoshi K, Komori T, Ozawa H 1999 Morphological characterization of skeletal cells in Cbfa1-deficient mice. Bone 25: 639651.
  • 15
    Kobayashi H, Gao YH, Ueta C, Yamaguchi A, Komori T 2000 Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem Biophys Res Commun 273: 630636.
  • 16
    Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A 1998 Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: Regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun 252: 697702.
  • 17
    Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL 1999 Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14: 15221535.
  • 18
    Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE 1998 Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142: 295305.
  • 19
    Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC 2000 Runx2 is a common target of transforming growth factor beta 1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 87838792.
  • 20
    Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR 1991 TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266: 1286612872.
  • 21
    Fletcher BS, Kujubu DA, Perrin DM, Herschman HR 1992 Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 267: 43384344.
  • 22
    Bazan NG, Fletcher BS, Herschman HR, Mukherjee PK 1994 Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci USA 91: 52525256.
  • 23
    Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA 1995 Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473482.
  • 24
    Okada Y, Lorenzo JA, Freeman AM, Tomita M, Morham SG, Raisz LG, Pilbeam CC 2000 Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture J Clin Invest 105: 823832.
  • 25
    Pilbeam CC, Rao Y, Voznesensky O, Kawaguchi H, Alander CB, Raisz LG, Herschman HR 1997 Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3–E1 cells. Endocrinology 138: 46724682.
  • 26
    Okada Y, Voznesensky O, Herschman HR, Harrison JR, Pilbeam CC 2000 Identification of multiplecis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells. J Cell Biochem 78: 197209.
  • 27
    Xie W, Herschman HR 1996 Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem 271: 3174231748.
  • 28
    Raisz LG, Simmons HA 1985 Effects of parathyroid hormone and cortisol on prostaglandin production by neonatal rat calvaria in vitro. Endocr Res 11: 5974.
  • 29
    Pilbeam CC, Fall PM, Alander CB, Raisz LG 1997 Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells. J Bone Miner Res 12: 11981203.
  • 30
    Schinke T, Karsenty G 1999 Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoters. J Biol Chem 274: 3018230189.
  • 31
    Kern B, Shen J, Starbuck M, Karsenty G 2001 Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes J Biol Chem 276: 71017107.
  • 32
    Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S 1998 Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17: 15171525.
  • 33
    Porte D, Tuckermann J, Becker M, Baumann B, Teurich S, Higgins T, Owen MJ, Schorpp-Kistner M, Angel P 1999 Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18: 667678.
  • 34
    Selvamurugan N, Brown RJ, Partridge NC 2000 Regulation of collagenase-3 gene expression in osteoblastic and non-osteoblastic cell lines. J Cell Biochem 79: 182190.
  • 35
    Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C 1999 Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19: 44314442.
  • 36
    Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM 1999 Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor betal in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 73: 114125.
  • 37
    Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT 2000 MÁPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1 J Biol Chem 275: 44534459.
  • 38
    Lou J, Tu Y, Li S, Manske PR 2000 Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2 Biochem Biophys Res Commun 268: 757762.
  • 39
    Hay E, Lemonnier J, Fromigue O, Marie PJ 2001 Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276: 2902829036.
  • 40
    Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo W-H, Imamura T, Ishidou Y, Fukuchi M, Shi M-J, Stavnezer J, Kawabata M, Miyazono K, Ito Y 1999 Interaction and functional cooperation of PEBP2/CBF with Smads. J Biol Chem 274: 3157731582.
  • 41
    Zhang Y-W, Yasui N, Ito K, Huang G, Fujii M, Hanai J, Nogami H, Ochi T, Miyazono K, Ito Y 2000 ARUNX2/PEBP2α/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97: 1054910554.
  • 42
    Flanagan AM, Chambers TJ 1992 Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2. Endocrinology 130: 443438.
  • 43
    Scutt A, Bertram P 1995 Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: Induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 10: 474487.
  • 44
    Jee WS, Ma YF 1997 The in vivo anabolic actions of prostaglandins in bone. Bone 21: 297304.
  • 45
    Weinreb M, Suponitzky I, Keila S 1997 Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone 20: 521526.
  • 46
    Okada Y, Tomita M, Gronowicz G, Kawaguchi H, Sohn J, Tanaka Y, Morimoto I, Nakamura T, Raisz LG, Pilbeam CC 2000 Effect of cyclooxygenase-2 gene disruption on osteoblastic function. J Bone Miner Res 15: S1; S217.
  • 47
    Nilsson OS, Persson PE 1999 Heterotopic bone formation after joint replacement. Curr Opin Rheumatol 11: 127131.
  • 48
    Reikeraas O, Engebretsen L 1998 Effects of ketoralac tromethamine and indomethacin on primary and secondary bone healing. An experimental study in rats. Arch Orthop Trauma Surg 118: 5052.
  • 49
    Dimar JR, Ante WA, Zhang YP, Glassman SD 1996 The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine 21: 18701876.
  • 50
    Traianedes K, Shima N, Mochizuki S, Yamaguchi K, Kinosaki M, Yano K, Shibata O, Udagawa N, Yasuda H, Suda T, Bonewald LF 1998 5-Lipoxygenase metabolites inhibit bone formation in vitro. Endocrinology 139: 31783184.